课题基金 / 基金详情

Quantitative neurochemical studies of effects of chronic delivery of GDNF

Quantitative neurochemical studies of effects of chronic delivery of GDNF
GDNF 慢性递送影响的定量神经化学研究
批准号:
6353142
负责人:
Greg A. Gerhardt
金额:
$16.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-01 至 2001-07-31

项目摘要

项目成果

Greg A. Gerhardt的其他基金

相似基金

相关文献

中文摘要
翻译
GDNF对中脑多巴胺(DA)神经元的神经修复和神经保护作用为帕金森病的治疗提供了一条有前景的治疗途径。我们的中心假设是,与其他给药方法相比,慢性脑室内或突变体内GDNF将对受损的DA神经元产生更大的疗效、效力和更小的副作用。我们建议使用一种新型的留置泵,可以在自由运动的单侧1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)病变猴子体内长期递送GDNF,以评估两个部位的递送:侧脑室和壳核。先前的研究表明,单次输注GDNF对大鼠和猴子的DA神经元具有神经保护和神经恢复作用,而DA神经元位于黑质而非纹状体。基于初步研究,我们假设,慢性给药GDNF将恢复黑质和纹状体区域的DA功能,与以前单次注射相比,产生更大的帕金森行为逆转。本项目的项目1将使用体内微透析、体内电化学和高效液相色谱结合电化学检测(HPLC-EC)对接受慢性GDNF输注的年轻成年恒河猴纹状体(壳核和尾状核)和黑质中的DA神经元系统进行定量神经化学评估。将进行洗脱研究以确定慢性GDNF效应的持续时间。重新植入研究也将进行,以确定GDNF是否可以维持或增加冲洗后的DA功能,并安全重新给药。在GDNF慢性递送过程中,这些猴子纹状体的神经化学变化将与行为、免疫组织化学、尿道追踪和功能MRI (fMRI)研究相结合,与项目2和项目3一起进行。这些研究将有助于更好地理解局灶性和持续性地向受损DA神经元递送强效DA致敏因子的作用。它们可能为帕金森病患者局灶性和慢性输送营养因子奠定基础。
英文摘要
The neurorestorative and neuroprotective tropic actions of GDNF on midbrain dopamine (DA) neurons provide a promising therapeutic approach for the treatment of Parkinson's disease. It is our central hypothesis that chronic intracerebroventricular or intraputamenal GDNF will produce effects on damaged DA neurons with greater efficacy, potency and reduced side effects as compared to other methods of delivery. We propose to use a novel indwelling pump that can deliver GDNF chronically in the freely-moving unilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesions monkey to evaluate two sites of delivery: the lateral ventricle and the putamen. Prior studies have shown that single infusions of GDNF produce neuroprotection and neurorestorative effects to DA neurons, which are localized to the substantia nigra and not the striatum of rats and monkeys. We hypothesize, based on preliminary studies, tha chronic delivery of GDNF will restore DA function in regions of the substantia nigra and striatum, producing a greater reversal of parkinsonian behavior than previously seen with single injections. Project 1 of this program project grant application will perform quantitative neurochemical assessments using in vivo micordialysis, in vivo electrochemical, and high performance liquid chromatography coupled with electrochemical detection (HPLC-EC) to study DA neuronal systems in the striatum (putamen and caudate nucleus) and substantia nigra of young adult Rhesus monkeys that have received chronic GDNF infusions. Washout studies will be performed to determine the longevity of the chronic GDNF effects. Re-instatement studies will also be performed to determine if GDNF can sustain or increase DA funciton following washout and be safely re-administered. These neurochemical changes to the monkey striatum during chronic delivery of GDNF will be performed in conjunction with behavioral, immunohistochemical, tract tracing and functional MRI (fMRI) studies of the same monkeys in conjunction with Project 2 and 3. These studies should lead to a greater understanding of the effects of focal and sustained delivery of a potent DA tropic factor to damaged DA neurons. They will likely lay the foundation for focal and chronic delivery of trophic factors to patients with Parkinson's disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tonic and Phasic Glutamate Release from Psychomotor Stimulants
  • 批准号:
    8446339
  • 项目类别:
  • 资助金额:
    $17.82万
  • 财政年份:
    2012
  • 负责人:
    Greg A. Gerhardt
  • 依托单位:
Tonic and Phasic Glutamate Release from Psychomotor Stimulants
  • 批准号:
    8322257
  • 项目类别:
  • 资助金额:
    $18.56万
  • 财政年份:
    2012
  • 负责人:
    Greg A. Gerhardt
  • 依托单位:
NEUROCHEMICAL STUDIES OF THE AGING BASAL GANGLIA
  • 批准号:
    7371007
  • 项目类别:
  • 资助金额:
    $17.26万
  • 财政年份:
    2007
  • 负责人:
    Greg A. Gerhardt
  • 依托单位:
Neuropharmacological Studies
  • 批准号:
    7009769
  • 项目类别:
  • 资助金额:
    $24.37万
  • 财政年份:
    2005
  • 负责人:
    Greg A. Gerhardt
  • 依托单位:
海外基金